Systemic sclerosis (SSc) is a rare multisystem disease characterized by early microvascular damage that leads to fibrosis of skin and internal organs [1]. SSc-related ocular manifestations have been poorly investigated. Different types of ocular involvement have been reported in patients with SSc: dry eyes, reduced choroidal thickness, astigmatism, posterior subcapsular cataract, increased intraocular pressure, eyelid abnormalities and retinal microcirculatory impairments [2,3]. A recent systematic literature review has reported that the most common ocular manifestations are eyelid skin fibrosis, dry eye disease, and involvement of the posterior segment, especially in the choroidal microvasculature [4,5].
